Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Street

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
Journal of Medicinal Chemistry|January 6, 2006
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disordersSimon C Goodacre, Leslie J Street, David J Hallett, et al.
Frontiers in Medicine|May 6, 2022
Preferences for HIV Testing Services and HIV Self-Testing Distribution Among Migrant Gay, Bisexual, and Other Men Who Have Sex With Men in AustraliaYe Zhang, Virginia Wiseman, Tanya L Applegate, et al.
Journal of Medicinal Chemistry|April 19, 2018
Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ <sup>null</sup> Mouse Model of MalariaAloysius T Nchinda, Claire Le Manach, Tanya Paquet, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyAndrew S R Jennings, Richard T Lewis, Michael G N Russell, et al.
Journal of Medicinal Chemistry|November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridinesDiego González Cabrera, Frederic Douelle, Yassir Younis, et al.
Journal of Medicinal Chemistry|June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding siteLeslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Journal of Medicinal Chemistry|November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal modelsRobert W Carling, Andrew Madin, Alec Guiblin, et al.
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Journal of Medicinal Chemistry|January 6, 2006
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disordersSimon C Goodacre, Leslie J Street, David J Hallett, et al.
Frontiers in Medicine|May 6, 2022
Preferences for HIV Testing Services and HIV Self-Testing Distribution Among Migrant Gay, Bisexual, and Other Men Who Have Sex With Men in AustraliaYe Zhang, Virginia Wiseman, Tanya L Applegate, et al.
Journal of Medicinal Chemistry|April 19, 2018
Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ <sup>null</sup> Mouse Model of MalariaAloysius T Nchinda, Claire Le Manach, Tanya Paquet, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietyAndrew S R Jennings, Richard T Lewis, Michael G N Russell, et al.
Journal of Medicinal Chemistry|November 30, 2012
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridinesDiego González Cabrera, Frederic Douelle, Yassir Younis, et al.
Journal of Medicinal Chemistry|June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding siteLeslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Journal of Medicinal Chemistry|November 11, 2005
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal modelsRobert W Carling, Andrew Madin, Alec Guiblin, et al.
Journal of Medicinal Chemistry|January 23, 2014
2,4-Diaminothienopyrimidines as orally active antimalarial agentsDiego González Cabrera, Claire Le Manach, Frederic Douelle, et al.
Journal of Medicinal Chemistry|November 10, 2015
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial RespirationRenier van der Westhuyzen, Susan Winks, Colin R Wilson, et al.
Pageof 25